OPKO Health Inc
(NAS:OPK)
$
1.5
+0.035 (+2.41%)
Market Cap: 1.13 Bil
Enterprise Value: 1.19 Bil
PE Ratio: 0
PB Ratio: 0.94
GF Score: 55/100 OPKO Health Inc at JPMorgan Healthcare Conference Transcript
Jan 14, 2026 / 09:30PM GMT
Release Date Price:
$1.3
(-2.99%)
Brian Cheng
JPMorgan Chase & Co - Analyst
Good afternoon, and welcome back. Thanks for joining us for another session at the 44th JPMorgan Healthcare Conference. I'm Brian Cheng. I'm one of the senior biotech analysts here at the firm. On stage, we have the team from OPKO Health.
And here, the session here is a fireside session with the team. Maybe the OPKO team can introduce themselves, who do we have on this stage?
Elias Zerhouni
OPKO Health Inc - President, Vice Chairman of the Board
Sorry. Can you hear me okay?
Brian Cheng
JPMorgan Chase & Co - Analyst
Yes.
Elias Zerhouni
OPKO Health Inc - President, Vice Chairman of the Board
I'm Elias Zerhouni, I'm the President of OPKO Health. I became President of OPKO Health because I cofounded a company called ModeX Therapeutics, which was acquired by OPKO Health in 2022. As part of that, I ended up being President of the acquiring company. And I'm a former Head of R&D at Sanofi, I'm a former Head of
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot